NCT00950599 - Study of Multiple Doses of Saxagliptin (BMS-477118) | Biotech Hunter

Enrollment

423

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Saxagliptin

Tablets, Oral, 2.5 mg, once daily, 12 weeks

DRUG

Saxagliptin

Tablets, Oral, 5 mg, once daily, 12 weeks

DRUG

Saxagliptin

Tablets, Oral, 10 mg, once daily, 12 weeks

DRUG

Saxagliptin

Tablets, Oral, 20 mg, once daily, 12 weeks

DRUG

Saxagliptin

Tablets, Oral, 40 mg, once daily, 12 weeks

DRUG

Saxagliptin

Tablets, Oral, 100 mg, once daily, 6 weeks

DRUG

Placebo

Tablets, Oral, 0 mg, once daily, 6 and 12 weeks